Breaking Headlines

Category archive

organizations

BREAKING: Direct Relief Makes $32 Million in Medical Inventories Available to Colombia and Peru amid Historic Flooding

in advocacy/BREAKING NEWS/charity/food/Health/healthcare/international/medical/medicine/non profit/organizations/poverty/Relief Effort by
Reading Time: 2 minutes

$200,000 Initial Cash Committed for Relief Effort, FedEx and Healthcare Companies Step Up as Emergency Unfolds

GOLETA, Calif., April 6, 2017 /360WiseNews/ — Direct Relief today committed an initial $200,000 in cash and made available $32 million in medical resources for relief and recovery efforts in Colombia and Peru, where historic flooding and mudslides have claimed hundreds of lives and displaced hundreds of thousands more.

Today’s commitment follows several emergency air shipments from Direct Relief of medical aid totaling $7.8 million and 38 tons (76,000 lbs.).

“People in Peru and Colombia are facing severe risks in the wake of devastating storms, and Direct Relief is extending support to our capable partner organizations providing frontline care in a still unfolding, complex emergency,” said Direct Relief President and CEO Thomas Tighe.

Water sources often become compromised after serious flooding, which can lead to a host of health issues. Cholera and other diseases related to poor sanitation pose additional threats to public health. Neglected tropical diseases including trachoma, soil-transmitted pathogens, and various bacterial and parasitic infections also present risks to people in the area.

Bolstered by strong support from corporate partners that include AbbVie, Allergan, Actavis, Baxter, BD, Boehringer Ingelheim, Teva, Pfizer, and Unilever, Direct Relief is sending antibiotics, antivirals, rehydration supplies and hygiene kits. FedEx has provided emergency airlift support.

In Peru, Direct Relief is assisting four partner organizations providing emergency services and conducting medical missions in close coordination with the Peruvian Ministry of Health. Patrulla Area Colombiana (PAC, a Colombian NGO of pilots and medics), Asociacion Paz Peru, Socios en Salud (Partners in Health), and Asociacion Vida Peru have received and distributed $3.9 million of essential medications and supplies totaling 17.5 tons to eight hard-hit regions: Lima, Huarmey, Piura, Pedregal Alto, Simbila, Tumbes, Casma, and Arequipa. Direct Relief also is funding the deployment of 20 medical personnel to Piura to provide medical care and deliver seven tons of medicine and medical supplies. Keep Reading

Higher Education Language Learning Solutions from Rosetta Stone Now Available at Studica

in BREAKING NEWS/Education/organizations/Partnership by
Reading Time: 2 minutes

SANBORN, N.Y., March 29, 2017 /360WiseNews/ — Studica, Inc. today announced it has entered into a new relationship with Rosetta Stone Inc. to offer affordable technology-based language-learning solutions to post-secondary education institutions. Colleges and universities, along with their students and faculty, will benefit from the trusted and proven language learning programs from Rosetta Stone, as well as Studica’s commitment to the education market.

“Working with Rosetta Stone is a perfect complement to Studica’s mission of offering the best education technology to our customers,” said Frank Nanfara, President and CEO of Studica, Inc. “Rosetta Stone offers a variety of powerful and effective solutions to help educators teach students new languages. Whether you are working with beginners, international students, English as a second language students, or more advanced language learners – Rosetta Stone will make you more successful.”

Studica has been partnering with innovative companies to provide exceptional software and technology products at affordable prices to schools, educators, and students since 1985. Through this new relationship, Studica will offer Rosetta Stone’s digital programs for beginner and advanced learners in higher education. These flexible solutions complement classroom instruction and provide management tools that maximize learner performance. Students attending post-secondary institutions are also eligible to purchase annual licenses at a special student discount at www.studica.com/Rosetta-Stone. Keep Reading

Essential Patent Data for the Top-100 IP Players Involved in the GaN Technology – Research and Markets

in BREAKING NEWS/Business and Finance/financial statements/organizations/Press Release/research market/Technology by
Reading Time: 5 minutes

DUBLIN, Mar. 15, 2017 /360WiseNews/ —

Research and Markets has announced the addition of the “GaN Technology Top-100 IP Profiles” report to their offering.

Research and Markets Logo

The report provides essential patent data for IP players related to GaN technology. It identifies 100 major patent holders involved in GaN technology, and its provides in a single slide the IP profile of each main patent holder including: time evolution of patent publications, geographic map of patenting activity, technical segments, highly cited patents, main IP competitors and IP collaborators.

Moreover, the current diversification of GaN-related research activities is remarkable, ranging from advanced optical sources and single-electron devices to physical, chemical, and biological sensors, optical detectors, and energy converters. In this dynamic and large context, it is necessary to have a clear overview of main companies and research laboratories involved in this technology domain.

Time evolution of patent publications shows the number of patent publications of the company between 1995 and 2016. The number of patent families related to GaN technology is also indicated. Moreover, for each country or geographical zone (USA, Europe, Korea, Japan, Taiwan and China), a mapping of patenting activity is presented. A patent portfolio segmentation is provided to understand the technologies claimed by each main assignee. This segmentation shows the number of patent families by application (LED, LASER, Power, RF and Crystal growth), growth substrate (Sapphire, Silicon, Silicon Carbide) and  growth technique (MOCVD, MBE, HVPE, Ammonothermal and LPE). A selection of patents receiving a high number of citations is provided to identify quickly key technologies filed by each patent assignee. Main competitors have been selected for each IP player. Keep Reading

Medical Ceramics Market is Expected to Reach $5,841 Million by 2022, Globally-Allied Market Research

in BREAKING NEWS/Business and Finance/Health/medical ceramics/medicine/organizations/Press Release by
Reading Time: 3 minutes

PORTLAND, Oregon and PUNE, India, March 15, 2017 /360WiseNews/ —

A new report published by Allied Market Research titled, Medical Ceramics Global Opportunity Analysis and Industry Forecast, 20142022“, projects that the global medical ceramics market was valued at $3,850 million in 2015, and is expected to reach $5,841 million by 2022, registering a CAGR of 6.2% from 2016 to 2022. Implants segment is expected to remain the highest revenue contributor throughout the forecast period. U.S. held the leading position in the global market in 2015, and is expected to maintain its lead throughout the study period.

 

Summary of the Medical Ceramics Market can be accessed on the website at:https://www.alliedmarketresearch.com/medical-ceramics-market

According to Eswara Prasad, Team Lead Chemical Research at Allied Market Research, Medical ceramics are widely preferred in dentistry due to their large compressive and load bearing capacity and similarity with dental materials such as enamel.

The upsurge in the demand for medical ceramics from medical device industry creates attractive opportunities for market growth. Properties of medical ceramics such as high compressive strength and biodegradability, which are necessary for bone implants are leading market growth. Medical ceramics minimize bone ingrowth, which is a key factor boosting its adoption in the market. Growth in applications of medical ceramics for inartificial total hip, knee, shoulder, elbow, wrist; bone plates, screws, wires; intramedullary nails; permanently implanted artificial limbs; spinal fusion; alveolar bone replacements, mandibular reconstruction; and tooth replacement implants has opened new growth avenues for medical ceramics market. Growth in ceramic implants market has also fueled the demand for medical ceramics as it can be framed to match the material properties of a natural bone.

The application of the medical ceramics in the implants segments holds highest share in 2015 and is expected to maintain its lead throughout the forecast period. The increase in use of ceramics as rigid materials to manufacture implants is due to absence of prosthetics, thus reducing the risk of bacterial growth. Zirconia and alumina are the most commonly used ceramic materials used to develop implants. Zirconia, a type of bio-inert ceramic is expected to be the fastest growing segment in the global medical ceramics market followed by piezo ceramics. Ceramics are preferred for orthopedic implants by manufacturers due to their high resistance and biochemical inertness. Alumina is the most commonly used ceramic utilized for manufacturing orthopedic implants. Keep Reading

New Collaboration Improves Access to Treatment for Familial Hypercholesterolemia (FH) Patients Most at Risk for Early Heart Attacks and Death

in advocacy/brands/BREAKING NEWS/Business and Finance/medicine/non profit/organizations/Partnership/pharmacy/Press Release by
Reading Time: 2 minutes

In collaboration with The FH Foundation, Express Scripts expands access to PCSK9 inhibitors for those with FH.

PASADENA, Calif., March 15, 2017 /360WiseNews/ — The FH Foundation, a patient-centered non-profit dedicated to research, advocacy, and education of all forms of familial hypercholesterolemia (FH), today announced its collaboration with Express Scripts, a leading pharmacy benefit manager, to improve pharmacy coverage for patients with FH, an inherited genetic disorder that causes high LDL-cholesterol from birth. With a more comprehensive set of diagnostic criteria, a broader group of patients will have access to cutting-edge PCSK9 inhibitor treatment, as appropriate.

“The FH Foundation applauds Express Scripts for its leadership, working with the FH Foundation to ensure that high-risk FH patients, for whom these novel therapies were approved, will have access to the care their healthcare provider has recommended,” said Katherine Wilemon, Founder and CEO of the Foundation. “Collaboration and open communication among stakeholders in the fragmented US healthcare system are vital to informing and delivering optimum care and improving health of the American public.”

More than 1.3 million Americans, or 1 in 250 people, suffer from FH, a genetic disorder that can significantly increase the risk for early heart disease and even death. Often undistinguished from other causes of high cholesterol, FH is under-diagnosed and undertreated. However, with early diagnosis and optimal treatment, the risk for heart disease can be lowered to almost that of the general population.

With these new, more inclusive criteria put into practice by Express Scripts last month, patients with an untreated LDL-cholesterol (LDL-C) equal to or greater than 190 mg/dL whose LDL-cholesterol is still over 70 mg/dL on maximally tolerated statins plus Zetia will qualify for prior authorization for a prescribed PCSK9 inhibitor. Other diagnostic criteria to better define the condition of FH were also added. Keep Reading

Qualtrics’ Groundbreaking Experience Management Launch Makes It Possible for Organizations to Close “Experience Gap”

in brands/BREAKING NEWS/Business and Finance/management/organizations by
Reading Time: 5 minutes

Industry’s first platform to address expanding gap between what organizations deliver and what customers and employees expect

Qualtrics’ experience management platform makes it easy to measure, prioritize, and optimize the experiences organizations provide across the four foundations of business: customer, product, employee and brand

SILICON SLOPES, Utah and SALT LAKE CITY, March 7, 2017 /360WiseNews/ — Qualtrics last week announced the Qualtrics XM Platform™, the world’s first experience management platform designed to address the growing experience gap––the gap between what organizations actually deliver and expectations from the market, customers and employees. Similar to how Salesforce and Workday have defined the evolving CRM and HRM categories, Qualtrics is creating the experience management category. The first solution in this space, the Qualtrics XM Platform, will help companies measure, prioritize, and optimize the experiences companies deliver across the four foundational aspects of business—customers, products, employees and brands.

Experience management helps organizations close the experience gap and achieve four key outcomes:

  • Customer Experience: Delight customers at every touchpoint;
  • Product Experience: Build products that people love;
  • Employee Experience: Improve employee engagement, retain top talent, and develop leaders;
  • Brand Experience: Create differentiated brands that people want to associate with.

According to Ryan Smith, CEO of Qualtrics, “There are two types of data: operational data and experience data. For too long, organizations have been looking exclusively at data about the past—the operational data or ‘O data.’ Where companies fail is in not leveraging experience data, or ‘X data.’ X data is the human-factor data, the beliefs, emotions, and sentiments that tell you why things are happening and that help predict what is going to happen next. And while there are plenty of technologies to help companies manage their operational data, until now there hasn’t been a technology that makes it easy to capture and understand the X data.”

Smith continued, “Because most organizations are O-data rich, and X-data poor, this has led to a huge gap between most companies’ ability to know what’s happening and understanding why it’s happening and how to adapt programs in real time. We call this the ‘experience gap’ and Qualtrics XM™, our experience management platform, is the key to helping companies close this gap.”

Growing Experience Expectations
The combination of new technologies, rapid advancements in customer experience (CX) programs and a younger consumer population is creating an immediate need for a platform to measure and optimize experiences across an organization. Millennials and Generation Z are fast becoming the largest population groups in the world. Both groups have higher expectations when it comes to brands, the products they buy and the experiences around them.

“The internet of things, wearables, self-driving cars, cashier-free stores, automated home assistants, Wi-Fi connected ordering buttons and deliveries by drone are leading the frenzied pack of experience expectations,” said Smith. “But to deliver great products and to provide delightful customer experience requires employee excellence across the organization. A company’s ability to win in today’s business environment depends on its ability to create amazing and consistent experiences across all aspects of the business.”

Customer Acclaim for Qualtrics XM Platform

Allianz
“Over the last 18 months, our partnership with Qualtrics has enabled Allianz Global Corporate & Specialty to more effectively support and manage our engagements with customers in over 30 countries. By having Qualtrics as a global platform integrating customer experience, market research and business data, we can better focus on the aspects of the customer journey that will not only have an impact on business performance but also will deliver the best customer experience,” said Allison Windon, Global Customer Experience Director at Allianz. “A key part of this approach has been to effectively use the insights gained to drive a customer-focused cultural change within our employees. And, as we look to the future, an experience management platform will become more and more important, as it is only through truly engaged team members that our customers can have the best experience.” Keep Reading

Go to Top